CXCL8 (54-72) is a chemokine fragment retaining key residues involved in receptor interaction and structural integrity. Its sequence supports β-sheet and loop conformations characteristic of chemokine cores. Researchers study its role in binding specificity and conformational shifts. Applications include immune-signaling research, motif analysis, and binding-profiling studies.
CXCL8 (54-72), also known as Interleukin-8 (IL-8) peptide fragment 54-72, is a specialized carbohydrate compound derived from the C-terminal region of the human CXCL8 chemokine. This peptide segment is recognized for its involvement in the intricate signaling pathways that regulate immune cell migration and inflammatory responses. Characterized by its unique amino acid sequence, CXCL8 (54-72) exhibits the ability to interact with specific receptors and glycosaminoglycans, making it a valuable tool for researchers investigating the molecular mechanisms of chemotaxis and cellular communication. Its structural and functional properties provide a versatile foundation for applications across immunological, biochemical, and cellular research disciplines, supporting advanced studies in both fundamental and applied sciences.
Immunology research: CXCL8 (54-72) serves as a critical reagent for dissecting the pathways of leukocyte migration and activation. By mimicking the active site of the native chemokine, this peptide fragment enables the study of neutrophil and monocyte chemotaxis in vitro, allowing researchers to investigate receptor-ligand interactions and downstream signaling events. Its use in migration assays and receptor binding studies facilitates the identification of key modulators and inhibitors that regulate immune cell trafficking, contributing to a deeper understanding of inflammatory processes and immune surveillance.
Receptor binding studies: The IL-8 (54-72) peptide fragment is widely employed in experiments designed to elucidate the specificity and affinity of chemokine receptors, particularly CXCR1 and CXCR2. By labeling or modifying the peptide, scientists can map binding domains, assess competitive inhibition, and characterize the structural determinants of receptor activation. These studies are essential for the development of novel receptor antagonists and the exploration of receptor-mediated signaling cascades, advancing the field of chemokine biology and aiding in the design of targeted molecular probes.
Glycosaminoglycan interaction analysis: As a segment with known affinity for glycosaminoglycans such as heparin and heparan sulfate, CXCL8 (54-72) is instrumental in research focused on extracellular matrix interactions. It enables the investigation of how chemokine fragments bind to and are modulated by matrix components, influencing their stability, localization, and bioactivity. Understanding these interactions is crucial for deciphering the spatial regulation of chemokine gradients in tissues and for developing strategies to modulate inflammatory cell recruitment in various physiological and pathological contexts.
Cell signaling pathway elucidation: The peptide fragment is frequently utilized to probe intracellular signaling events triggered by chemokine-receptor engagement. By applying CXCL8 (54-72) to cultured cells, researchers can monitor the activation of downstream effectors such as kinases, phosphatases, and transcription factors. These experiments shed light on the molecular mechanisms that govern cell migration, adhesion, and survival, offering insights into the orchestration of immune responses and the potential for therapeutic intervention in dysregulated signaling networks.
Inflammatory model development: CXCL8 (54-72) is incorporated into in vitro and ex vivo models to simulate aspects of inflammatory microenvironments. Its capacity to induce chemotactic and signaling responses in target cells makes it an ideal component for constructing models of acute and chronic inflammation. These systems are invaluable for screening anti-inflammatory compounds, studying the dynamics of immune cell infiltration, and unraveling the complex interplay between chemokines, their receptors, and the tissue matrix in disease-relevant settings.
Biotechnological innovation: The unique properties of the IL-8 (54-72) peptide fragment have inspired its application in the development of novel bioassays and analytical tools. Researchers leverage its receptor and glycosaminoglycan binding capabilities to design sensitive detection platforms, competitive binding assays, and affinity purification strategies. These innovations not only enhance the precision of chemokine research but also support the discovery of new molecular targets and the optimization of experimental techniques in immunology and cell biology. Through its multifaceted applications, CXCL8 (54-72) continues to drive advances in the understanding of chemokine function and the broader landscape of cell signaling and immune regulation.
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More